<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T23:31:59+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>这家企业净利润最高增幅达7000%！医疗器械高光、中药两极分化，94家企业预告业绩，2020年好像没那么难？</title>
    <updated>2021-01-22T20:41:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/AFB2hCu6I_yYlU6nyJTJgg</id>
    <link href="https://mp.weixin.qq.com/s/AFB2hCu6I_yYlU6nyJTJgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>面对未来医疗的转型，这家药企指出了方向</title>
    <updated>2021-01-22T20:41:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/1J31ke3UaiOmupWrOKe0cw</id>
    <link href="https://mp.weixin.qq.com/s/1J31ke3UaiOmupWrOKe0cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>未盈利上市药企注意了！过半产品销售峰值不足这个数！</title>
    <updated>2021-01-21T21:32:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/T1cDiFHDk3LrLcvVqqhO1A</id>
    <link href="https://mp.weixin.qq.com/s/T1cDiFHDk3LrLcvVqqhO1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从少有问津到资本追逐，这家创新药企能成为中国抗生素市场的解局者吗？</title>
    <updated>2021-01-21T21:32:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/-q4qbAxLlBjkwTnmBk-NKw</id>
    <link href="https://mp.weixin.qq.com/s/-q4qbAxLlBjkwTnmBk-NKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>济民可信新冠病毒特异性中和抗体JMB2002启动I期临床试验</title>
    <updated>2021-01-21T21:32:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/PN-MkzkUlDPrES6x7PsnPw</id>
    <link href="https://mp.weixin.qq.com/s/PN-MkzkUlDPrES6x7PsnPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下滑50%！2020年全球生物医药收并购案TOP10公布！这家公司却出手阔绰欲转型！</title>
    <updated>2021-01-20T21:19:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/dkEBnFLUxcaAFBwvhZisSA</id>
    <link href="https://mp.weixin.qq.com/s/dkEBnFLUxcaAFBwvhZisSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点 2020 | 药圈数字化转型元年，丁香园在做什么？</title>
    <updated>2021-01-20T21:19:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/AO62Ua4__-LbwY3CY7qvsg</id>
    <link href="https://mp.weixin.qq.com/s/AO62Ua4__-LbwY3CY7qvsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>私域流量+精准营销+数智体验，大健康人才招聘新范式</title>
    <updated>2021-01-20T21:19:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/aXh5sRfjGdizYTzqhjJG0A</id>
    <link href="https://mp.weixin.qq.com/s/aXh5sRfjGdizYTzqhjJG0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来、豪森两款降糖药公布谈判价格，降幅超50%，市场格局将大变！这款国产新药一同进入医保却受到质疑……</title>
    <updated>2021-01-19T21:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/CXQiyT1mMCk8uJ0GG2iO6Q</id>
    <link href="https://mp.weixin.qq.com/s/CXQiyT1mMCk8uJ0GG2iO6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅国际创新药VASCEPA®登陆海南，撬动中国心血管领域“后他汀”时代</title>
    <updated>2021-01-19T21:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/f3MILobLOq0rcMdmFEEn5g</id>
    <link href="https://mp.weixin.qq.com/s/f3MILobLOq0rcMdmFEEn5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一万年太久，做好产品只争朝夕！</title>
    <updated>2021-01-19T21:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/PyIhBqb8YkDCyVujFggEQA</id>
    <link href="https://mp.weixin.qq.com/s/PyIhBqb8YkDCyVujFggEQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫情之下，2021年全球生物医药行业七大趋势预测！下一个风口在这里！</title>
    <updated>2021-01-18T20:49:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/qwK4piPaGwxJHHDVeRGuAg</id>
    <link href="https://mp.weixin.qq.com/s/qwK4piPaGwxJHHDVeRGuAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝康医疗：基因检测创新引领者 独具先发优势</title>
    <updated>2021-01-18T20:49:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/E39G7KpqlR4GBEn9ElssrA</id>
    <link href="https://mp.weixin.qq.com/s/E39G7KpqlR4GBEn9ElssrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>看跨国药企如何玩转零售，益普生签约保健食品</title>
    <updated>2021-01-18T20:49:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/D5B85jNd6IrU20eNjnHSrw</id>
    <link href="https://mp.weixin.qq.com/s/D5B85jNd6IrU20eNjnHSrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球53.3%临床在中国！首款国产CAR-T即将上市，高昂定价谁来买单？</title>
    <updated>2021-01-17T20:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/HjDVPNw2lASvjCvUQVGa4Q</id>
    <link href="https://mp.weixin.qq.com/s/HjDVPNw2lASvjCvUQVGa4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>估值回调，上市套利时代结束，分拆继续，投资人眼中的2021</title>
    <updated>2021-01-17T20:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/dIHocSJuYf-WRPoQWIgYfw</id>
    <link href="https://mp.weixin.qq.com/s/dIHocSJuYf-WRPoQWIgYfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>普瑞基准通过中国前列腺癌HRR检测校准计划</title>
    <updated>2021-01-17T20:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/x1NeVnUnQ4PYsII3yrlPUQ</id>
    <link href="https://mp.weixin.qq.com/s/x1NeVnUnQ4PYsII3yrlPUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进中国:深挖本土需求，打开在华加速新局面</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/wAPQxeiKrJ26BywRVyO2Vw</id>
    <link href="https://mp.weixin.qq.com/s/wAPQxeiKrJ26BywRVyO2Vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进：四十载创新变革—布局全球，加速中国正当时</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/lZbmXWlTkH49jWhpGQO2bw</id>
    <link href="https://mp.weixin.qq.com/s/lZbmXWlTkH49jWhpGQO2bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>柯美玲：每个女性用自己力量改变世界的故事都令人振奋</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/CBd0p_ikpCkR4pc3kEPzqw</id>
    <link href="https://mp.weixin.qq.com/s/CBd0p_ikpCkR4pc3kEPzqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>